Hillsdale Investment Management Inc. Veru Inc. Transaction History

Hillsdale Investment Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.58 - $3.36 $563,957 - $734,455	-218,588 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$3.01 - $4.02 $657,949 - $878,723	218,588 New	218,588 $730,000
Q1 2020 May 12, 2020	SELL	$2.58 - $4.58 $878,397 - $1.56 Million	-340,464 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$1.86 - $3.35 $13,020 - $23,450	-7,000 Reduced 2.01%	340,464 $1.14 Million
Q3 2019 Nov 13, 2019	BUY	$1.81 - $2.36 $628,909 - $820,015	347,464 New	347,464 $751,000

115

58M

539K

367K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $60.1M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.